Sign in or Register   Sign in or Register
  |  

Mouse Anti-TET2 (N-terminus) Recombinant Antibody (CBFYM-3155) (CBMAB-M3352-FY)

This product is mouse antibody that recognizes TET2. The antibody CBFYM-3155 can be used for immunoassay techniques such as: IP, WB.
See all TET2 antibodies

Summary

Host Animal
Mouse
Specificity
Human, Mouse
Clone
CBFYM-3155
Application
IP, WB

Basic Information

Immunogen
Recombinant protein containing the N-terminal 300 amino acids of human TET2 (tet oncogene family member 2)
Specificity
Human, Mouse
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS
Preservative
0.05% Sodium azide
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Epitope
N-terminus

Target

Full Name
TET2 Gene(Protein Coding) Tet Methylcytosine Dioxygenase 2
Introduction
The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene.
Entrez Gene ID
Human54790
Mouse214133
UniProt ID
HumanQ6N021
MouseQ4JK59
Alternative Names
Tet Methylcytosine Dioxygenase 2; KIAA1546; Tet Oncogene Family Member 2; EC 1.14.11.n2; Probable Methylcytosine Dioxygenase TET2; Methylcytosine Dioxygenase TET2; MDS
Function
Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Has a preference for 5-hydroxymethylcytosine in CpG motifs. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, also involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.
Biological Process
Biological Process 5-methylcytosine catabolic processSource:UniProtKB1 Publication
Biological Process cell cycleSource:UniProtKB-KW
Biological Process chromatin organizationSource:UniProtKB-KW
Biological Process DNA demethylationSource:UniProtKB1 Publication
Biological Process histone H3-K4 trimethylationSource:UniProtKB1 Publication
Biological Process leukocyte differentiationSource:UniProtKB1 Publication
Biological Process myeloid cell differentiationSource:UniProtKB1 Publication
Biological Process oxidative demethylationSource:GO_Central1 Publication
Biological Process oxidative DNA demethylationSource:UniProtKB1 Publication
Biological Process positive regulation of transcription by RNA polymerase IISource:UniProtKB2 Publications
Biological Process protein O-linked glycosylationSource:UniProtKB1 Publication
Biological Process response to organic cyclic compoundSource:Ensembl
Cellular Location
Nucleus
Involvement in disease
Polycythemia vera (PV):
A myeloproliferative disorder characterized by abnormal proliferation of all hematopoietic bone marrow elements, erythroid hyperplasia, an absolute increase in total blood volume, but also by myeloid leukocytosis, thrombocytosis and splenomegaly.
Myelodysplastic syndrome (MDS):
A heterogeneous group of closely related clonal hematopoietic disorders. All are characterized by a hypercellular or hypocellular bone marrow with impaired morphology and maturation, dysplasia of the myeloid, megakaryocytic and/or erythroid lineages, and peripheral blood cytopenias resulting from ineffective blood cell production. Included diseases are: refractory anemia (RA), refractory anemia with ringed sideroblasts (RARS), refractory anemia with excess blasts (RAEB), refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS); chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative disease. MDS is considered a premalignant condition in a subgroup of patients that often progresses to acute myeloid leukemia (AML).
Immunodeficiency 75 (IMD75):
An autosomal recessive immunologic disorder characterized by recurrent infections, mainly viral and affecting the respiratory tract, immunodeficieny, immune dysregulation, and the development of lymphoproliferative disorders, including lymphoma.
PTM
May be glycosylated. It is unclear whether interaction with OGT leads to GlcNAcylation. According to a report, it is not GlcNAcylated by OGT (PubMed:23353889).
In contrast, another group reports GlcNAcylation by OGT in mouse ortholog.
Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-TET2 (N-terminus) Recombinant Antibody (CBFYM-3155)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare